Agios Pharmaceuticals, Inc. (AGIO) — DEF 14A Filings
All DEF 14A filings from Agios Pharmaceuticals, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Agios Pharmaceuticals DEF 14A Filing Details Executive Compensation
— Apr 25, 2025 Risk: low
Agios Pharmaceuticals, Inc. filed its DEF 14A on April 25, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and ot -
AGIOS PHARMACEUTICALS, INC. DEF 14A Filing
— Apr 26, 2024 Risk:
AGIOS PHARMACEUTICALS, INC. (AGIO) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. AGIOS PHARMACEUTICALS, INC. filed a DEF 14A on April 26, 20
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX